John is the Chief Operating Officer at Tobin Capital Group, leading all operational and finance efforts. Previously, John was the youngest Brand Manager in Eli Lilly’s 147-year history (47k+ employees). By redefining Lilly’s end-of-life-cycle strategy for FORTEO, he generated over $1.32 billion in additional revenue, where none had been expected. He also developed an innovative deal structure that secured formulary access for TALTZ at CVS Caremark.
John holds an MBA from the Stanford Graduate School of Business and a Master of Public Policy from Stanford University. He earned his undergraduate degree from DePauw University, where he was inducted into the Phi Beta Kappa Honor Society. He loves focusing on physical fitness, nutrition, and longevity.
John is the Chief Operating Officer at Tobin Capital Group, leading all operational and finance efforts. Previously, John was the youngest Brand Manager in Eli Lilly’s 147-year history (47k+ employees). By redefining Lilly’s end-of-life-cycle strategy for FORTEO, he generated over $1.32 billion in additional revenue, where none had been expected. He also developed an innovative deal structure that secured formulary access for TALTZ at CVS Caremark.
John holds an MBA from the Stanford Graduate School of Business and a Master of Public Policy from Stanford University. He earned his undergraduate degree from DePauw University, where he was inducted into the Phi Beta Kappa Honor Society. He loves focusing on physical fitness, nutrition, and longevity.
550 California St
Suite 116
San Francisco, CA
94104
© Tobin Capital Group 2025
550 California St
Suite 116
San Francisco, CA
94104
© Tobin Capital Group 2025
